Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-α blockade.
- Published in:
- Clinical Rheumatology, 2010, v. 29, n. 7, p. 763, doi. 10.1007/s10067-010-1402-x
- By:
- Publication type:
- Article
Works matching IS 07703198 AND DT 2010 AND VI 29 AND IP 7
Results: 22
1
2
Renal cortical necrosis at presentation in a patient with systemic lupus erythematosus: an autopsy case report.
- Published in:
- 2010
- By:
- Publication type:
- Report
3
Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximab.
- Published in:
- Clinical Rheumatology, 2010, v. 29, n. 7, p. 723, doi. 10.1007/s10067-010-1388-4
- By:
- Publication type:
- Article
4
Primary Sjogren’s syndrome with anticentromere antibodies—a clinically distinct subset.
- Published in:
- 2010
- By:
- Publication type:
- Report
5
Erosive osteoarthritis: a current review of a clinical challenge.
- Published in:
- Clinical Rheumatology, 2010, v. 29, n. 7, p. 697, doi. 10.1007/s10067-009-1369-7
- By:
- Publication type:
- Article
6
The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis.
- Published in:
- 2010
- By:
- Publication type:
- Report
7
Adult presentation of Stickler syndrome type III.
- Published in:
- 2010
- By:
- Publication type:
- Report
8
Diffuse systemic sclerosis and autoimmune hepatitis: a unique association.
- Published in:
- 2010
- By:
- Publication type:
- Report
9
Expressions of IL-18 and its binding protein in peripheral blood leukocytes and kidney tissues of lupus nephritis patients.
- Published in:
- Clinical Rheumatology, 2010, v. 29, n. 7, p. 717, doi. 10.1007/s10067-010-1386-6
- By:
- Publication type:
- Article
10
A case of Hughes–Stovin syndrome associated with hyperhomocysteinemia.
- Published in:
- 2010
- By:
- Publication type:
- Report
11
Exertional paraspinal muscle rhabdomyolysis and compartment syndrome: a cause of back pain not to be missed.
- Published in:
- 2010
- By:
- Publication type:
- Report
12
Off-label use of rituximab in systemic lupus erythematosus: a systematic review.
- Published in:
- Clinical Rheumatology, 2010, v. 29, n. 7, p. 707, doi. 10.1007/s10067-010-1387-5
- By:
- Publication type:
- Article
13
An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis.
- Published in:
- 2010
- By:
- Publication type:
- Report
14
Reinforcing a medical hypothesis with a new question: is there a subgroup of shrinking lungs syndrome that is induced by pleurisy in systemic lupus erythematosus and is this subgroup marked by anti-Ro/SSA?
- Published in:
- 2010
- By:
- Publication type:
- Report
15
Validity, reliability, and comparison of the WOMAC osteoarthritis index and Lequesne algofunctional index in Turkish patients with hip or knee osteoarthritis.
- Published in:
- Clinical Rheumatology, 2010, v. 29, n. 7, p. 749, doi. 10.1007/s10067-010-1398-2
- By:
- Publication type:
- Article
16
Renal disease in systemic sclerosis with normal serum creatinine.
- Published in:
- Clinical Rheumatology, 2010, v. 29, n. 7, p. 729, doi. 10.1007/s10067-010-1389-3
- By:
- Publication type:
- Article
17
Osteoarthritis of the hip or knee: which coexisting disorders are disabling?
- Published in:
- Clinical Rheumatology, 2010, v. 29, n. 7, p. 739, doi. 10.1007/s10067-010-1392-8
- By:
- Publication type:
- Article
18
The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.
- Published in:
- Clinical Rheumatology, 2010, v. 29, n. 7, p. 771, doi. 10.1007/s10067-010-1403-9
- By:
- Publication type:
- Article
19
Juvenile idiopathic arthritis among Nigerians: a case study.
- Published in:
- Clinical Rheumatology, 2010, v. 29, n. 7, p. 757, doi. 10.1007/s10067-010-1401-y
- By:
- Publication type:
- Article
20
Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?
- Published in:
- 2010
- By:
- Publication type:
- Letter
21
Erratum to: Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice